Author

Maria A.A. de Jong

Observed names: Maria A A De Jong, Maria A. A. De Jong

Institution: Radiotherapeutisch Instituut Friesland

Observed institution: Radiotherapeutisch Instituut Friesland

OpenAlex ID: A5124311410

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial

2025 · Anne Sophie V M van den Heerik, Nanda Horeweg, et al. · The Lancet Oncology · 78

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial

2026 · Anne Sophie V.M. van den Heerik, Nanda Horeweg, et al. · Radiotherapy and Oncology · 4

Toxicity, health-related quality of life and sexuality after molecular profile-based adjuvant treatment in high-intermediate risk endometrial cancer, PORTEC-4a

2026 · Anne Sophie V. M. Van den Heerik, Cathalijne C. B. Post, et al. · British Journal of Cancer

Works count: 3

Citation count: 82

H-index: 2

I10-index: 1